OmniScience Joins TransCelerate BioPharma as a Solution Collaboration Forum Member

Houston, TX – May 27th, 2026 – OmniScience is proud to announce its membership in the TransCelerate BioPharma Solution Collaboration Forum, joining a global network of biopharmaceutical leaders, technology innovators, health authorities, and research organizations united by a shared commitment to transforming clinical development.

TransCelerate BioPharma is a non-profit catalyst for change in clinical research, uniting voices across biopharmaceutical R&D to drive innovation, simplify clinical trials, and help bring new treatments to patients faster, safer, and more efficiently. That mission resonates deeply with our own. At OmniScience, we are on a mission to transform clinical trial operations so that life-changing medicines reach patients faster, and we believe that progress at the scale the industry needs requires exactly the kind of cross-sector collaboration TransCelerate enables.

"TransCelerate represents the industry collaboration we need to improve clinical trials - to get more medicines to patients, faster and at lower cost. We are honored to be invited to join this community." Said Angela Holmes, OmniScience CEO.

As a Solution Collaboration Forum Member, OmniScience looks forward to contributing our expertise in agentic AI, real-time clinical trial intelligence, and unified data infrastructure to the broader effort of making clinical development more efficient, evidence-driven, and patient-centered. We are honored to take our place in this community and eager to help shape the next era of clinical research alongside the leaders driving it forward.